HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease
Free-Photos / Pixabay

HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease

According to a story from PR Newswire, the Hereditary Neuropathy Foundation (HNF) recently announced that it will be conducting a meeting with the US Food and Drug Administration (FDA). This…

Continue Reading HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease
A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
paulbr75 / Pixabay

A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink

According to a story from The Chicago Tribune, Darnesha Bankston, age 23, was rushed to the hospital just before Christmas last year with a bunch of severe, life threatening symptoms.…

Continue Reading A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome
lisichik / Pixabay

Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome

According to a story from the Santa Cruz Sentinel, the earliest results from a critical gene editing study could offer some encouragement for those hoping to treat rare genetic diseases…

Continue Reading Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome
Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation
Hans / Pixabay

Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the gene therapy company Reflection Biotechnologies Ltd. recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to its…

Continue Reading Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation